Aydin Huseynov analyst LADENBURG

Currently out of the existing stock ratings of Aydin Huseynov, 49 are a BUY (84.48%), 9 are a HOLD (15.52%).

Aydin Huseynov

Work Performance Price Targets & Ratings Chart

Analyst Aydin Huseynov, currently employed at LADENBURG, carries an average stock price target met ratio of 36.9% that have a potential upside of 52.56% achieved within 259 days.

Aydin Huseynov’s has documented 108 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on NXTC, NextCure  at 06-Nov-2025.

Wall Street Analyst Aydin Huseynov

Analyst best performing recommendations are on INO (INOVIO PHARMACEUTICALS).
The best stock recommendation documented was for INO (INOVIO PHARMACEUTICALS) at 5/21/2020. The price target of $336 was fulfilled within 35 days with a profit of $165.12 (96.63%) receiving and performance score of 27.61.

Average potential price target upside

CALA Calithera Biosciences INCY yte INO Inovio Pharmaceuticals NKTR Nektar Therapeutics REGN Regeneron Pharmaceuticals SLS Sellas Life Sciences Group SPRB Spruce Biosciences  VYGR Voyager Therapeutics NXTC NextCure  ALLR Allarity Therapeutics ATHE Alterity Therapeutics Ltd CMPX Compass Therapeutics PCSA Processa Pharmaceuticals TRIL Trillium Therapeutics PALI Palisade Bio CRVS Corvus Pharmaceuticals CGTX Cognition Therapeutics TPST Tempest Therapeutics CAPR Capricor Therapeutics MRKR Marker Therapeutics ACRV Acrivon Therapeutics, Common Stock ALRN Aileron Therapeutics IONS Ionis Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$2

$1.97 (6566.67%)

$2

3 years 5 days ago
(15-Nov-2022)

3/4 (75%)

$-0.38 (-15.97%)

53

Buy

$8

$7.97 (26566.67%)

3 years 2 months 22 days ago
(29-Aug-2022)

0/1 (0%)

$4.17 (108.88%)

Buy

$140

$139.97 (466566.66%)

5 years 6 months 9 days ago
(11-May-2020)

0/2 (0%)

$3.2 (2.34%)

Buy

$340

$339.95 (679900.00%)

$240

8 years 7 months 22 days ago
(29-Mar-2017)

3/3 (100%)

$110.33 (71.65%)

163

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Aydin Huseynov is most bullish on?

Potential upside of $8.12 has been obtained for NXTC (NEXTCURE )

What Year was the first public recommendation made by Aydin Huseynov?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?